The utilization of patient-derived organoids as a platform for predicting the efficacy of anti-cancer drugs: Chemotherapy, targeted therapy, and immunotherapy. This is an ASCO Meeting Abstract from ...
The protein p53 is often called the guardian of the genome for its central role in preventing cancer. Yet paradoxically, it ...
Figure 2: Schematic depicting hypothesized cooperation between HPV and COVID in suppressing p53 and contributing to cancer.
A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, Lipofen) as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results